ITGA2 and chronic myelogenous leukemia, BCR-ABL1 positive: We previously reported that ITGA2 is upregulated in K562R cells compared to K562S cells [6], and this finding is further supported by bioinformatic analysis of CML patient datasets, suggesting a potential role for ITGA2 in drug resistance and clinical relevance.